MoneyWorks4Me

Net sales declined -19.61%  to  Rs. 529.37 million from Rs. 658.53 millions.A big decline of -39.14% was reported for the quarter ended September 2021 to Rs. 56.21  millions from Rs. 92.36 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 83.94 millions from 135.79 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 529.37 658.53 -19.61 1042.06 950.93 9.58 2448.05 2055.11 19.12
Other Income 27.25 13.13 107.54 40.56 22.12 83.36 71.41 52.22 36.75
PBIDT 83.94 135.79 -38.18 167.23 185.99 -10.09 449.80 218.62 105.75
Interest 1.20 0.47 155.32 3.09 0.81 281.48 2.71 4.60 -41.09
PBDT 82.74 135.32 -38.86 164.49 185.18 -11.17 447.39 213.50 109.55
Depreciation 9.74 10.00 -2.60 19.45 19.99 -2.70 40.35 40.61 -0.64
PBT 73.00 125.32 -41.75 145.04 165.19 -12.20 407.04 172.89 135.43
TAX 16.79 32.96 -49.06 34.86 43.17 -19.25 115.32 30.36 279.84
Deferred Tax 0.12 2.66 -95.49 0.06 0.87 -93.10 2.31 -13.97 -116.54
PAT 56.21 92.36 -39.14 110.18 122.02 -9.70 291.72 142.53 104.67
Equity 829.95 780.65 6.32 829.95 780.65 6.32 789.95 780.65 1.19
PBIDTM(%) 15.86 20.62 -23.10 16.05 19.56 -17.95 18.37 10.64 72.72
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..